# EDGAR Filing Document

**Accession Number:** 0001156375
**File Stem:** 0001193125-26-105815
**Filing Date:** 2026-3
**Character Count:** 28221
**Document Hash:** 0acac465058a2118bf51e960e4d8f21a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-105815.hdr.sgml**: 20260313

**ACCESSION NUMBER**: 0001193125-26-105815

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260313

**EFFECTIVENESS DATE**: 20260313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CME GROUP INC.
- **CENTRAL INDEX KEY:** 0001156375
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 364459170
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294275
- **FILM NUMBER:** 26751690

**BUSINESS ADDRESS:**
- **STREET 1:** 20 S. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 3129301000

**MAIL ADDRESS:**
- **STREET 1:** 20 S. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHICAGO MERCANTILE EXCHANGE HOLDINGS INC
- **DATE OF NAME CHANGE:** 20010802

As filed with the Securities and Exchange Commission on March 13, 2026.

**Registration No. 333-** 

**United States Securities and Exchange Commission** 

**Washington, DC 20549** 

**Form S-8** 

**Registration Statement Under the Securities Act of 1933** 

**CME Group Inc.** 

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **36-4459170** |
| (State or other jurisdiction of incorporation or<br> organization) | (I.R.S. Employer Identification No.) |
| **20 South Wacker Drive**<br> **Chicago, Illinois** | **60606** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan** 

(Full title of the plan)

**Jonathan Marcus, Esq.** 

**Senior Managing Director and General Counsel** 

**CME Group Inc.** 

**20 South Wacker Drive** 

**Chicago, Illinois 60606** 

(Name and address of agent for service)

**(312) 930-1000** 

(Telephone number, including area code, of agent for service)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large accelerated filer ☒ | Accelerated filer ☐ |
| Non-accelerated filer ☐ | Smaller reporting company ☐ |
|  | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE** 

CME Group Inc. (the "Company") is filing this registration statement for the purpose of registering 1,500,000 shares of the Company's Class A Common Stock, par value $.01 per share (the "Class A Common Stock"), authorized for issuance in connection with awards under the CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan (the "Omnibus Stock Plan").

**Part I** 

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS** 

The documents containing the information specified in Part I of Form S-8 will be sent or given to participants in the Omnibus Stock Plan as required by Rule 428(b)(1) under the Securities Act of 1933, as amended (the "Securities Act"). In accordance with Rule 428(b) under the Securities Act and the note to Part I of Form S-8, those documents are not being filed with the Securities and Exchange Commission (the "SEC") as a part of this registration statement.

**Part II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

**Item 3. Incorporation of Documents by Reference.** 

The following documents filed with the SEC by the Company pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are incorporated by reference in this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1156375/000115637526000009/cme-20251231.htm) for the fiscal year ended December 31, 2025, filed with the SEC on February 26, 2026; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the description of the Class 
A Common Stock set forth in [Exhibit 4.11](http://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/cme-2021123110kex411.htm) to the Company's Annual Report on Form 10-K for
the fiscal year ended December 31, 2021, filed with the SEC on February 2, 2022.

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

**Item 4. Description of Securities.** 

Not applicable.

------

**Item 5. Interests of Named Experts and Counsel.** 

The validity of the shares of Class A Common Stock being registered pursuant to this registration statement has been passed upon by Margaret A. Wright, Associate General Counsel of the Company. Ms. Wright is a beneficial owner of shares of Class A Common Stock and is eligible to participate in the CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan.

**Item 6. Indemnification of Directors and Officers.** 

Section 145 of the General Corporation Law of the State of Delaware (the "DGCL") authorizes a court to award or a corporation's board of directors to grant indemnity to directors and officers in terms sufficiently broad to permit such indemnification under some circumstances for liabilities arising under the Securities Act and to provide for the reimbursement of expenses incurred.

As permitted by Delaware law, Article Eleven of the Company's certificate of incorporation and Article VIII of the Company's bylaws provide that (1) the Company shall indemnify its directors and officers and former directors and officers to the fullest extent permitted by law; (2) such indemnification includes the right to advancement of expenses if the Company has received an undertaking by the person receiving such advance to repay all amounts advanced if it should be determined that he or she is not entitled to be indemnified by the Company; and (3) the rights to indemnification conferred in the Company's certificate of incorporation and bylaws are not exclusive. As permitted by the DGCL, Article Ten of the Company's certificate of incorporation includes a provision that eliminates the personal liability of the Company's directors for monetary damages for breach of fiduciary duty as a director, except for liability (a) for any breach of the director's duty of loyalty to the Company or its shareholders; (b) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; (c) under Section 174 of the DGCL (regarding payments of dividends, stock purchases or redemptions which are unlawful); or (d) for any transaction from which the director derived an improper personal benefit. This provision in the Company's certificate of incorporation does not eliminate the directors' fiduciary duty, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director's duty of loyalty to the Company for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director and for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director's responsibilities under any other law, such as the federal securities laws or state or federal environmental laws.

The foregoing statements are subject to the detailed provisions of Section 145 of the DGCL and the full text of the Company's certificate of incorporation and bylaws. Copies of the Company's certificate of incorporation and bylaws have been filed as exhibits to this registration statement.

The Company maintains, at its expense, a policy of insurance which insures its directors and officers, subject to exclusions and deductions as are usual in these kinds of insurance policies, against specified liabilities which may be incurred in those capacities.

**Item 7. Exemption from Registration Claimed.** 

Not applicable.

------

**Item 8. Exhibits.** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 4.1 | [Fourth Amended and Restated Certificate of Incorporation of CME Group Inc. (incorporated by reference to Exhibit 3.2 to CME Group Inc.'s Current Report on Form 8-K filed with the SEC on November 4, 2021).](http://www.sec.gov/Archives/edgar/data/1156375/000119312521319504/d204323dex32.htm) |
| 4.2 | [Seventeenth Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.'s Current Report on Form 8-K filed with the SEC on December 9, 2022).](http://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/d412380dex31.htm) |
| 5.1 | [Opinion of Margaret A. Wright, Associate General Counsel of CME Group Inc.](d120078dex51.htm) |
| 23.1 | [Consent of Ernst & Young LLP.](d120078dex231.htm) |
| 23.2 | [Consent of Margaret A. Wright (included in Exhibit 5.1).](d120078dex51.htm) |
| 24.1 | [Power of attorney (included on signature pages to this registration statement).](#sig) |
| 99.1 | [CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Current Report on Form 8-K filed with the SEC on March 7, 2024).](http://www.sec.gov/Archives/edgar/data/1156375/000119312524062191/d14382dex101.htm) |
| 107 | [Filing fee table.](d120078dexfilingfees.htm) |

---

**Item 9. Undertakings.** 

(a) The undersigned registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee Tables" or
"Calculation of Registration Fee" table, as applicable, in the effective registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in the
registration statement or any material change to such information in the registration statement;

*Provided, however, That*: Paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering.

(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public
policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chicago, State of Illinois, on March 13, 2026.

---

| | |
|:---|:---|
| **CME GROUP INC.** | **CME GROUP INC.** |
| By: | /S/ LYNNE FITZPATRICK |
|  | Lynne Fitzpatrick |
|  | President and Chief Financial Officer |

---

**POWER OF ATTORNEY** 

Each person whose signature appears below constitutes and appoints Terrence A. Duffy, Lynne Fitzpatrick and Jonathan Marcus, and each of them, as such person's true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person and in such person's name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and any instruments necessary or appropriate in connection therewith, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing required or necessary to be done in and about the premises, as fully to all intents and purposes as such person may or could do in person, and hereby ratifies and confirms all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This power of attorney may be executed in counterparts.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on March 13, 2026.

---

| | |
|:---|:---|
| **Signature** | **Title** |
| /S/ TERRENCE A. DUFFY<br> **Terrence A. Duffy** | Chairman of the Board, Director and Chief Executive Officer (Principal Executive Officer and Director) |
| /S/ LYNNE FITZPATRICK<br> **Lynne Fitzpatrick** | Senior Managing Director, President and Chief Financial Officer (Principal Financial Officer) |
| /S/ JACK TOBIN<br> **Jack Tobin** | Managing Director and Chief Accounting Officer (Principal Accounting Officer) |
| /S/ KATHRYN BENESH<br> **Kathryn Benesh** | Director |

---

------

---

| | |
|:---|:---|
| **Signature** | **Title** |
| /S/ TIMOTHY S. BITSBERGER<br> **Timothy S. Bitsberger** | Director |
| /S/ CHARLES P. CAREY<br> **Charles P. Carey** | Lead Director |
| /S/ ELIZABETH A. COOK<br> **Elizabeth A. Cook** | Director |
| /S/ BRYAN T. DURKIN<br> **Bryan T. Durkin** | Director |
| /S/ HAROLD FORD JR.<br> **Harold Ford Jr.** | Director |
| /S/ MARTIN J. GEPSMAN<br> **Martin J. Gepsman** | Director |
| /S/ WILLIAM W. HOBERT<br> **William W. Hobert** | Director |
| /S/ DANIEL G. KAYE<br> **Daniel G. Kaye** | Director |
| /S/ PHYLLIS M. LOCKETT<br> Phyllis M. Lockett | Director |
| /S/ DEBORAH J. LUCAS<br> **Deborah J. Lucas** | Director |
| /S/ PATRICK W. MALONEY<br> **Patrick W. Maloney** | Director |

---

------

---

| | |
|:---|:---|
| **Signature** | **Title** |
| /S/ PATRICK J. MULCHRONE | Director |
| **Patrick J. Mulchrone** |  |
| /S/ RAHAEL SEIFU | Director |
| **Rahael Seifu** |  |
| /S/ WILLIAM R. SHEPARD | Director |
| **William R. Shepard** |  |
| /S/ HOWARD J. SIEGEL | Director |
| **Howard J. Siegel** |  |
| /S/ DENNIS A. SUSKIND | Director |
| **Dennis A. Suskind** |  |
| /S/ ROBERT J. TIERNEY JR. | Director |
| **Robert J. Tierney Jr.** |  |

---

## Exhibit 5.1

**Exhibit 5.1**![LOGO](g120078g0312030934912.jpg)

March 13, 2026

CME Group Inc.

20 South Wacker Drive

Chicago, Illinois 60606

Re: CME Group Inc. Registration Statement on Form S-8

Ladies and Gentlemen:

I am the Associate General Counsel of CME Group Inc., a Delaware corporation (the "Company"). This opinion is delivered in connection with the Company's registration statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Securities Act"), to be filed on the date hereof with the U.S. Securities and Exchange Commission (the "Commission") relating to the registration of 1,500,000 shares (the "Shares") of the Company's Class A Common Stock, par value $.01 per share (the "Class A Common Stock"), authorized for issuance in connection with awards under the CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan (the "Plan").

This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.

In rendering the opinion stated herein, I or lawyers under my supervision have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of the following: (i) the Registration Statement; (ii) the certificate of incorporation of the Company; (iii) the Seventeenth Amended and Restated Bylaws of the Company; (iv) the Plan; and (v) minutes of a meeting of the Compensation Committee of the Board of Directors of the Company relating to approval of the Plan. I or lawyers under my supervision have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and receipts of public officials, certificates of officers or other representatives of the Company and others, and such other documents, certificates and records as I have deemed necessary or appropriate as a basis for the opinion stated below.

In our examination, I and the lawyers under my supervision have assumed the genuineness of all signatures, including electronic signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified or photocopied copies, and the authenticity of the originals of such copies. In making our examination of executed documents, I and the lawyers under my supervision have assumed that the parties thereto, other than the Company, had the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action,

------

CME Group Inc.

March 13, 2026

corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. As to any facts relevant to the opinion stated herein that I or lawyers under my supervision did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others and of public officials.

The opinion stated herein is subject to the following qualifications: (a) I have assumed that, prior to the issuance of any Shares, the Company and the recipient of such Shares pursuant to an award under the Plan will have duly entered into an applicable award agreement, such award agreement will be consistent with the terms of the Plan and will be duly authorized, validly executed and delivered by the parties thereto, and the issuance of such Shares will be in accordance with the terms of the Plan and such award agreement; (b) I have assumed that, prior to the issuance of any Shares, the Company will have received the consideration contemplated by the applicable resolutions of the Board of Directors of the Company or a committee thereof authorizing the issuance of such Shares and/or the consideration contemplated pursuant to the terms of the Plan (including any consideration provided for in an award agreement) and that the consideration for each such Share will not be less than the par value thereof; (c) I have assumed that, upon the issuance of any Shares, an appropriate account statement evidencing such Shares credited to the recipient's account maintained with the Company's transfer agent will have been issued by the Company's transfer agent for the Class A Common Stock; and (d) I have assumed that the issuance of the Shares will be properly recorded in the books and records of the Company.

I am admitted to the bar in the State of Illinois. I do not express any opinion as to the laws of any jurisdiction other than the General Corporation Law of the State of Delaware (the "DGCL"), and I do not express any opinion as to the effect of any other laws on the opinion stated herein.

Based upon the foregoing and subject to the limitations, qualifications, exceptions and assumptions stated herein, I am of the opinion that the Shares have been duly authorized by all requisite corporate action on the part of the Company under the DGCL and, when issued, delivered and paid for in accordance with the terms of the Plan and the applicable award agreement, will be validly issued, fully paid and nonassessable.

I assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if I become aware of any fact that might change the opinion stated herein after the date hereof.

------

CME Group Inc.

March 13, 2026

I hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent, I do not thereby admit that I am within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.

Very truly yours,

![LOGO](g120078g0312030936024.jpg)

Margaret A. Wright

Associate General Counsel

CME Group Inc.

## Exhibit 23.1

**Exhibit 23.1** 

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan of our reports dated February 26, 2026, with respect to the consolidated financial statements of CME Group Inc. and the effectiveness of internal control over financial reporting of CME Group Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Chicago, Illinois

March 13, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**CME GROUP INC.**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Security Type**  | **Security Class Title**  | **Fee Calculation Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| 1 | Equity | Class A Common Stock, par value $.01 per share | Other | 1500000 | $317.225 | $475837500.00 | 0.0001381 | $65713.16 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $475837500.00  |  | $65713.16  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $65713.16  |

---

 **Offering Note** <br>

<sup>1</sup> The amount registered consists of 1,500,000 shares of Class A Common Stock, par value $.01 per share, of CME Group Inc. ("Class A Common Stock") authorized for issuance in connection with awards under the CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan (the "Omnibus Stock Plan"). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), the registration statement shall be deemed to cover any additional shares of Class A Common Stock to be offered or issued under the Omnibus Stock Plan pursuant to terms that provide for a change in the amount of securities being offered or issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions. The proposed maximum offering price per unit and the maximum aggregate offering price are estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) and Rule 457(h) under the Securities Act. The maximum aggregate offering price is calculated as the average of the high and low prices reported for a share of Class A Common Stock on The Nasdaq Stock Market on March 6, 2026.

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---